Written by Prabha Raghavan | New Delhi | Updated: October 24, 2020 7:52:13 am Covaxin: the country’s first indigenous vaccine is an inactivated one created from the infectious virus strain SARS-CoV-2. BHARAT BIOTECH, who has received approval for late stage human trials for its Covid vaccine candidate, it expects to …
Read More »Covaxin, made in India, is licensed for phase III trials 5 updates
The Subject Matter Expert Committee (SEC) of the Comptroller General of Drugs of India (DCGI) recommended the granting of permission to conduct Phase III clinical trials for Bharat Biotech’s Covid-19 Covaxin vaccine. The panel added that the recommendation is after evaluating the Phase I and II data, as well as …
Read More »The possibility of a second wave of Covid-19 during winters cannot be ruled out: VK Paul from NITI Aayog – health
NITI Aayog member VK Paul said Sunday that the number of new cases of the coronavirus disease (Covid-19) and related deaths have declined across the country in the last three weeks, but the possibility of a second wave of infections during the winter season can not. be ruled out, according …
Read More »Covid-19 vaccine: healthy young people may have to wait until 2022, says WHO
The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »Covid Cases May Increase During Winter: Health Minister Harsh Vardhan
By: Express Web Desk | New Delhi | Updated: October 11, 2020 6:22:47 pm Union Health Minister Harsh Vardhan during ‘Sunday Samvaad’, an interaction with his followers on social media. The Union Health Minister Harsh Vardhan hinted on Sunday that India could see an increase in the rate of Covid-19 …
Read More »Indian Coronavirus Vaccine: All Options on the Table to Secure Covid Vaccines | India News
NEW DELHI: India is exploring all options, including the provisions of the Essential Products Act, the Medicines and Cosmetics Act, and the Disaster Management Act, to secure adequate stocks and negotiate a reasonable price for Covid injections, even as the large-scale national vaccine. manufacturing capabilities give you a solid edge …
Read More »Center estimates to use 40-50 cr COVID-19 vaccine doses in 20-25 cr people by July 2021: Harsh Vardhan
By: PTI | New Delhi | Updated: October 4, 2020 4:10:40 pm Union Health Minister Harsh Vardhan during ‘Sunday Samvaad’, an interaction with his followers on social media. The Center estimates to receive and use doses of 40 to 50 crore of the COVID-19 vaccine covering 20 to 25 crore …
Read More »Coronavirus Vaccine: From Covaxin to Russian Vaccine Launch, Here Are All Updates on COVID-19 Vaccine Development
Amid controversy and news of accelerated trials abroad, the latest report on Sputnik V suggests that the vaccine may meet its promised target and offers tolerable immunity after the first injection. Alexander Gintsburg, director of Moscow’s Gamaleya state research institute, which runs the trials, said that enough samples have been …
Read More »Launch of Covid-19 vaccine portal, all data linked to research, clinical trial, says Harsh Vardhan
The Union Ministry of Health launched an online portal on Covid-19 on Monday with the latest information on the coronavirus disease. The web portal will have data on the development of the research, clinical trials on a possible Covid-19 vaccine in India, its launch date and other information, said Health …
Read More »‘Your arrangements will take care of everything’: Adar Poonawalla praises PM Modi’s vaccine vision
A day after questioning India’s financial plan to purchase and distribute the Covid-19 vaccine, Serum Institute of India Executive Director Adar Poonawalla has praised Prime Minister Narendra Modi’s vision of providing vaccines to the global community. We share and applaud your vision @Narendra Modi hee, about supplying vaccines to the …
Read More »